When manual work slows discovery, patients wait longer.
A global leader in life sciences faced an all-too-common challenge. Creating complex clinical study protocols was time-consuming, labor-intensive, and depended on a shrinking pool of medical writers. Every new clinical trial protocol meant a race against deadlines, rising costs, and mounting regulatory demands. The old way could not keep up with the industry’s growing need for speed, quality, and compliance.
Persistent was brought in to break the cycle and set a new pace for progress.
The Challenge: Too Much Manual, Too Little Momentum
The process relied on scarce experts and repetitive, manual drafting of dense regulatory documents. With too few skilled hands and no way to accelerate, approvals slowed down. The risks were clear: delayed study launches, missed market opportunities, and mounting pressure from sponsors and regulators.
The organization needed a way to deliver faster, more consistent results, without sacrificing accuracy or compliance.
The Approach: GenAI as a Force Multiplier
Persistent introduced a GenAI-powered platform designed for clinical trial protocol automation. The solution integrated scientific knowledge, regulatory guidance, and domain-specific requirements into a seamless, AI-driven writing workflow. Drafting clinical trial protocols became a process of collaboration between subject matter experts and GenAI, writing, validating, and refining in a fraction of the time.
Every clinical trial protocol draft was grounded in scientific rigor, cited sources, and compliant templates. Review cycles became faster and more reliable, all within a secure, enterprise-ready environment.
Impact: Clinical Trial protocols at the Speed of Science
The change was immediate and dramatic:
- Protocol drafting was up to 60 percent faster
- Quality improved by 40 percent, with every claim linked to supporting evidence
- Total cost to create protocols dropped by 50 percent
- Study teams accelerated approvals, and patients could access treatments sooner
What was once a labor barrier became a competitive advantage for innovation and growth.
Why Persistent?
- Life sciences expertise with proven results in regulated environments
- Track record of delivering scalable, domain-specific GenAI solutions
- Focus on measurable business value, not just technical milestones
- Collaborative approach with scientific, regulatory, and technology teams
From Manual to Momentum
With Persistent, the organization moved from slow, manual work to rapid, intelligent protocol creation. The impact was felt across teams, timelines, and ultimately in the speed at which new therapies reach patients.
Ready to bring GenAI momentum to your most complex processes? Connect with Persistent’s AI Transformation Team.
